Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prostate Cancer, Castration Resistant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT06895811
What this trial is testing

Clinical Study of Safety and Efficacy of Universal PSMA CAR- T in Refractory CRPC

Who this might be right for
Metastatic Prostate CancerCastration-resistant Prostate CancerMetastatic Castration-resistant Prostate Cancer
Shanghai Changzheng Hospital 3
Early research (Phase 1)Active Not RecruitingNCT04506567
What this trial is testing

Fractionated and Multiple Dose 225Ac-J591 for Progressive mCRPC

Who this might be right for
Prostate Cancer
Weill Medical College of Cornell University 60
Testing effectiveness (Phase 2)Study completedNCT03392428
What this trial is testing

A Trial of 177Lu-PSMA617 Theranostic Versus Cabazitaxel in Progressive Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Cancer of the ProstateMetastatic Cancer
Australian and New Zealand Urogenital and Prostate Cancer Trials Group 201
Early research (Phase 1)Study completedNCT03123978
What this trial is testing

Enzalutamide and Niclosamide in Treating Patients With Recurrent or Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Metastatic Prostate CarcinomaRecurrent Prostate CarcinomaStage IV Prostate Cancer
University of California, Davis 6
Not applicableStudy completedNCT02450812
What this trial is testing

Non-interventional Study With Ra-223 Dichloride Assessing Overall Survival and Effectiveness Predictors for mCRPC Patients in a Real Life Setting in Germany

Who this might be right for
Prostatic Neoplasms, Castration-Resistant
Bayer 86
Testing effectiveness (Phase 2)Looking for participantsNCT06216249
What this trial is testing

Phase 2 Randomized Trial of Flexible Dosing Schedule of 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer (FLEX-MRT)

Who this might be right for
Prostate CarcinomaStage IVB Prostate Cancer American Joint Committee on Cancer (AJCC) v8
Jonsson Comprehensive Cancer Center 90
Testing effectiveness (Phase 2)Study completedNCT02512458
What this trial is testing

Study of the Effect of Chemotherapy With Cabazitaxel on Prostate Cancer

Who this might be right for
Bone Metastatic Prostate Cancer
Hellenic Cooperative Oncology Group 60
Early research (Phase 1)WithdrawnNCT05807126
What this trial is testing

Testing the Addition of Immunotherapy With Hu5F9-G4 (Magrolimab) to the Usual PARP Inhibitor, Olaparib for Treatment of Metastatic or Recurrent Breast or Castrate-Resistant Prostate Cancer With BRCA Mutations

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Castration-Resistant Prostate CarcinomaStage IVB Prostate Cancer AJCC v8
National Cancer Institute (NCI)
Early research (Phase 1)Active Not RecruitingNCT05479578
What this trial is testing

Cyclophosphamide and Dexamethasone for the Treatment of Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Prostate AdenocarcinomaStage IVB Prostate Cancer American Joint Committee on Cancer (AJCC) V8
Rashmi Verma, MD 7
Early research (Phase 1)Study completedNCT01094288
What this trial is testing

Alisertib Participants With Advanced Solid Tumors Including Castration-Resistant Prostate Cancer Receiving a Standard Docetaxel Regimen

Who this might be right for
Advanced Solid TumorsAdenocarcinoma of the Prostate
Millennium Pharmaceuticals, Inc. 41
Testing effectiveness (Phase 2)Ended earlyNCT02964988
What this trial is testing

UPAR PET/CT in Radium-223-dichloride Treatment of Patients With Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Prostate Cancer MetastaticBone Metastases
Rigshospitalet, Denmark 17
Very early researchNot Yet RecruitingNCT06546527
What this trial is testing

Study of [177Lu]Lu-PSMA-137 In Metastatic Castrate Resistant Prostate Cancer（mCRPC）

Who this might be right for
Prostate Cancer
Peking University First Hospital 12
Early research (Phase 1)Temporarily pausedNCT05425862
What this trial is testing

Pidnarulex and Talazoparib in Patients With Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Metastatic Castration Resistant Prostate Cancer (mCRPC)
Peter MacCallum Cancer Centre, Australia 48
Large-scale testing (Phase 3)Active Not RecruitingNCT05204927
What this trial is testing

177Lu-PSMA-I&T for Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Metastasis From Malignant Tumor of Prostate
Curium US LLC 439
Very early researchNot Yet RecruitingNCT07609225
What this trial is testing

Chemical-Shift-Encoded MRI for Active Bone Marrow Dosimetry in Radiopharmaceutical Therapy

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
University of Wisconsin, Madison 15
Testing effectiveness (Phase 2)UnknownNCT05156450
What this trial is testing

TQB3616 Capsules Combined With Abiraterone Acetate Plus Prednisone in Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Prostatic Neoplasms, Castration-ResistantDrug Therapy, Combination
West China Hospital 30
Not applicableUnknownNCT04833517
What this trial is testing

Prospective REgistry of Targeted RadionucLide TherapY in Patients With mCRPC (REALITY Study)

Who this might be right for
Prostate Cancer MetastaticCastration Resistant Prostatic CancerAdvanced Prostate Carcinoma
Universität des Saarlandes 500
Testing effectiveness (Phase 2)Looking for participantsNCT06236139
What this trial is testing

Cell Therapy (STEAP1 CART) With Enzalutamide for the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Metastatic Castration-Resistant Prostate CarcinomaMetastatic Prostate AdenocarcinomaStage IVB Prostate Cancer AJCC v8
Fred Hutchinson Cancer Center 48
Early research (Phase 1)Ended earlyNCT02698176
What this trial is testing

A Dose Exploration Study With Birabresib (MK-8628) in Participants With Selected Advanced Solid Tumors (MK-8628-006)

Who this might be right for
NUT Midline Carcinoma (NMC)Triple Negative Breast Cancer (TNBC)Non-small Cell Lung Cancer (NSCLC)+1 more
Merck Sharp & Dohme LLC 13
Testing effectiveness (Phase 2)Study completedNCT01540071
What this trial is testing

Trial of NRX 194204 in Castration- and Taxane-Resistant Prostate Cancer

Who this might be right for
Castration Resistant Prostate Cancer
Io Therapeutics 38
Next Page